NCT05117801 (PETALE) is a NA clinical trial of Petale in Petale, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT05117801?

NCT05117801 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT05117801?

Interventions in NCT05117801: Petale.

What condition does NCT05117801 study?

NCT05117801 studies Petale, Hearing Disorders, Child Development.

Is NCT05117801 still recruiting?

NCT05117801 is currently status unknown. Last updated 11 November 2021.

Last reviewed 2021-11-11 · How we verify

NCT05117801: PETALE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician

Status unknown NA Last updated 11 November 2021

What this trial tests

NA trial testing Petale in Petale in 300 participants. Status unknown.

Timeline

4 January 2021

Primary endpoint
4 October 2021

4 July 2022

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	300
Start date	4 January 2021
Primary completion	4 October 2021
Estimated completion	4 July 2022
Sites	1 location across France

Drugs / interventions tested

Petale

Conditions studied

Petale — all drugs for Petale →
Hearing Disorders — all drugs for Hearing Disorders →
Child Development — all drugs for Child Development →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

Adults 9 Months to 3, any sex, with Petale or Hearing Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to confirm the value of this new version of Pétale® ((small equipment for testing the child's hearing) in the daily practice of general practitioners or pediatricians for the screening of hearing disorders in very young children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05117801 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 11 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05117801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing